QUOTED. 12 September 2019. David Ferguson.
Executive Summary
Baxter International is buying Israeli fluid-management company Cheetah Medical in a $230m deal set to expand Baxter’s patient monitoring portfolio. See what Baxter's David Ferguson said about it here.
"The robust capabilities and innovative monitoring technologies we will gain with the acquisition of Cheetah Medical will be additional strategic growth drivers as we work to eliminate preventable harm and enable personalized therapy for hospitalized patients around the world.” – David Ferguson, general manager of medication delivery, Baxter International Inc.
- Find out more: Baxter Runs With Cheetah Medical In $230M Deal